Ideal CBD 750 mg

by Barlean's · softgel capsule · 30 softgels

  • Off the market since September 2020 (NIH)
  • UPC 7 05875 80114 0
  • DSLD label 216081
  • Serving 1 softgel
  • 30 servings

Ideal CBD 750 mg by Barlean's lists 2 ingredients, 2 with an amount per serving of 1 softgel, such as 35 mg of full spectrum hemp extract and 25 mg of cannabinoid, beside 1 Nutrition Facts row (calories, fat and the like). Its current label entered the NIH Dietary Supplement Label Database on March 24, 2020.

What is in Ideal CBD 750 mg?

Each row as the label prints it, per serving of 1 softgel. The capsule beside an amount places it among every product in the NIH database that lists the same ingredient: the bar is the middle half of their amounts, the line in it the median, the whiskers the 10th and 90th percentiles; the green tick is the FDA Daily Value and the red dashed tick the adult upper limit (IOM).

Ideal CBD 750 mg: Supplement Facts rows against the market (DSLD label 216081, January 2026 release)
IngredientAmount% DVAmong products listing it
Calories5 Calories
Total Fat0 g1%
full spectrum Hemp extract35 mgHemp in Ideal CBD 750 mg against 351 products35 mg per serving; the middle half of products list 20 mg to 50 mg, the median 30 mg.35 mg

Higher than 57% of 351 products listing hemp (median 30 mg).

Cannabinoid25 mgCannabinoids in Ideal CBD 750 mg against 126 products25 mg per serving; the middle half of products list 21.9 mg to 1,000 mg, the median 281.5 mg.25 mg

69% of 126 products listing cannabinoids give more (median 281.5 mg).

Source: NIH ODS Dietary Supplement Label Database, label 216081 (entered March 24, 2020), version 9.4.0. See the label on DSLD. Amounts are what the maker printed; DSLD does not test products. Daily Values: the FDA's Daily Value page.

Is that a lot?

Every amount on this label with a position sits within the middle 80% of the products that list the same ingredient.

The NIH database records one serving a day from the label's directions; its % Daily Values are for adults and children 4 or more years of age. The directions as printed are further down this page.

The Tolerable Upper Intake Level is the most of a nutrient per day, from food, water and supplements together, that is likely to pose no risk for almost all adults (Institute of Medicine, 2011). It does not apply under medical supervision. This page compares labels; it is not medical advice.

Sources: amounts from the DSLD label; Daily Values from 21 CFR 101.9(c)(8)(iv); adult upper limits from the Institute of Medicine's DRI summary tables (2011). How positions are computed.

Which products have the closest formulas?

3 products list the very same ingredients; the nearest amounts come first.

Source: ingredient lists of every product's current label in DSLD (version 9.4.0); similarity weights each shared ingredient by how rare it is.

What does the label say about taking it?

Quoted from the label as DSLD transcribed it: the maker's words, including any claim about what the product does, which the FDA has not evaluated and PlainVitamins does not endorse.

Directions
Directions for use: 1 softgel as needed.
Warnings
Warning: Keep out of reach of children; not intended for use under the age of 18.
Consult your physician if you have a medical condition or are taking any medications. Do not take if you are pregnant or nursing.
Allergens and what it does not contain
Non-GMO Gluten free BPA and Phthalate free bottle
Storage
Keep bottle tightly closed. Store in a cool, dry place.

Source: label statements in DSLD label 216081.

What else is on the label?

Other ingredients: MCT Oil, Softgel, Full Spectrum Hemp Extract.

How many labels does Ideal CBD 750 mg have?

One label is on file, entered on March 24, 2020.

  1. Label 216081 (current) Entered March 24, 2020 · off the market September 15, 2020 · 30 softgels · UPC 7 05875 80114 0

Source: DSLD label entry and market events, version 9.4.0 (labels entered through September 25, 2025).

Who makes it?

The label names Barlean's (manufacturer), Ferndale, WA. All Barlean's products.

Where next?